Fine Chemicals Corporation (FCC) Cape Town-based FCC manufactures narcotic and specialist fine APIs and supplies these to the South African market and numerous export territories. FCC is accredited by the FDA, MCC and PMDA and is a 50% joint venture which Aspen currently holds with Matrix Laboratories. A recent agreement has however been reached for Aspen to acquire the remaining 50% of FCC subject to the fulfillment of certain conditions. For more information about FCC click on Fine Chemicals Corporation (FCC): Cape Town-based FCC manufactures narcotic and specialist fine APIs and supplies these to the South African and numerous export markets. FCC is accredited by the US FDA, MCC, PIC and PMDA (Japan).
Investment is being made to increase the capacity and enhance GMP compliance levels at FCC to create additional capability for contained manufacturing at this API facility.
This is in alignment with the Group’s vertical integration objectives for selected global brands.
The construction of the high potency API laboratory, as well as the expansion and refurbishment of the administration areas, were recently completed. An upgrade and expansion project for selected manufacturing blocks on the site and for the enhancement of supporting quality systems commenced in 2011 and is phased over a period of five years.
During September 2011 the facility was re-accredited by the US FDA.
For more information about FCC click on http://www.fcc.co.za